Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

Smartprofit Finder

Startseite
Schweiz
Zürich
Smartprofit Finder

Anrufen Wegbeschreibung Website Service kontaktieren

FINMA-authorised Swiss asset manager combining independent investment judgement with proprietary quantitative technology.

17/10/2026

Hadrian's deal with Lockheed Martin isn't just a contract — it's a signal that automated manufacturing has become a strategic weapon in its own right. A startup is no longer pitching at the factory gate. It's embedded inside Lockheed's Missiles and Fire Control facility in Texas, running precision machining cells powered by software, automation, and real industrial accountability. The best defense designs mean nothing if you can't build enough parts, fast enough, at scale. With $1.37B raised at a $7.87B valuation, capital is clearly chasing this bottleneck. And the real prize? Throughput — controlled, repeatable, data-driven production that doesn't flinch under pressure. The future belongs to whoever builds at the speed of urgency. 🔗 https://illustrated-ai.com/hadrians-lockheed-deal-signals-a-new-era-in-defense-manufacturing-automation/

16/10/2026

AI drug discovery just got a $1.5B vote of confidence — but only $40M is real money right now. Insitro and AstraZeneca struck a major partnership targeting MASH and cardiomyopathies — two diseases with massive unmet need. The structure reveals everything: one side brings an AI platform combining human genetic data, cellular experiments, and machine learning to find what actually *causes* disease, not just what accompanies it. The other brings global scale and clinical muscle. The milestone-heavy deal keeps both sides honest. Show the science works, and the economics grow. That's not hype — that's how serious bets get made. Read the full breakdown: https://illustrated-ai.com/ai-drug-discovery-partnership-insitro-and-astrazenecas-1-5b-bet/

15/10/2026

AI infrastructure is the real battleground — not just who builds the smartest models, but who provides the machinery that makes AI work at scale. In every gold rush, the tool suppliers shape the era. One company made that point impossible to ignore: valued at $4.65B in May, it closed a new round at $15.75B just five months later — a 3.4x leap. Usage tripled. Revenue crossed $1B annualized run rate, growing 15x year-on-year. The driver? AI agents need somewhere to work. Sandboxes — instant, disposable ex*****on environments — are critical for coding agents and accounted for $300M of that figure alone. The real question is whether explosive growth converts into durable economics. Full breakdown here: https://illustrated-ai.com/modals-ai-infrastructure-surge/

14/10/2026

🏗️ $200M just landed in construction robotics — and it's not just about robots building walls anymore. The real shift? A company that once used its own machines is now putting them in the hands of outside builders. That's when technology stops being a novelty and starts becoming an industry. Think robot + printable material + software + support — a full system designed to slash construction timelines and cut costs. If it works for ordinary builders in real-world conditions, this becomes a true platform business with recurring revenue from equipment, materials, and services. Housing is one of the economy's most stubborn markets. The opportunity is enormous. But bold vision only matters if third-party builders can use this profitably without inventors standing beside them. The hard part starts now. 👇 https://illustrated-ai.com/icons-200m-bet-on-3d-printed-homebuilding-scale/

13/10/2026

CMR Surgical just secured ~$400M from Stryker — and this is bigger than a funding round. Stryker becomes the exclusive U.S. sales agent for Versius, CMR's modular surgical robot designed to slot into existing operating rooms rather than disrupt them. With 45,000+ patients treated globally, this isn't a prototype. It's a proven platform gaining one of medicine's most powerful commercial engines behind it. The structure is clever: strategic capital, exclusive sales rights, and a future acquisition option. Stryker gets a foothold in surgical robotics without building from scratch. CMR gets reach without surrendering control. Surgical robotics is entering its industrial phase — where distribution muscle matters as much as innovation. Read the full breakdown here 👉 https://illustrated-ai.com/cmr-surgicals-400m-stryker-alliance/

12/10/2026

A $7 billion takeover discussion around Decart signals something bigger than one headline: the AI race is entering a new phase where efficiency beats brilliance. Decart builds world models — responsive AI environments that change in real time, not just static outputs. Think live video transformation, virtual training worlds for robotics, and dynamic digital twins. When AI builds worlds instead of clips, it becomes enterprise infrastructure. The real prize? Compute efficiency. Running AI at scale is brutally expensive. Decart's ability to operate across multiple chip architectures reduces hardware dependence and cuts latency — making it strategically irreplaceable for cloud giants fighting to own the full AI stack. Valuation jumped from $4B to $7B in months. The market is paying attention. The brightest spotlight hits the demo. The real treasure sits in the engine room. Read the full breakdown: https://illustrated-ai.com/amazon-decart-and-the-7b-bet-on-ai-infrastructure/

11/10/2026

TypeSafe AI compressed years into 24 days. After launching Jev in mid-September, the company closed an $870M Series A at a $7.5B valuation, led by Andreessen Horowitz with Sequoia and DCVC participating. The jump from a $40M seed round was 21.8x — in under a month. What makes Jev different? Most AI talks. Jev decides. It delivers structured outputs — typed choices, scores, and probabilities — that enterprise software can immediately act on. Less digital essayist, more dependable decision engine. The real bet: millions of invisible micro-decisions power the global economy. TypeSafe AI wants to own that infrastructure layer. Promising? Absolutely. But adoption claims need verification, and competition is fierce. Read the full breakdown 👉 https://illustrated-ai.com/typesafe-ais-breakout-funding-for-decision-focused-enterprise-ai/

10/10/2026

Warehouse robots are no longer showpieces — they're clocking in. One robotics company reports over 500,000 packed orders, proving that repetitive, reliable work beats viral demos every time. E-commerce runs on millions of small moments, and robots handling even part of that process reshape retail economics from the inside out. A subscription-style model — integration fee plus monthly payments — lowers the barrier to entry, but unit economics still determine winners. Utilization, uptime, and service costs matter more than the pitch deck. The real edge? An AI partnership turning every packed order into live training data. Smarter robots, wider task ranges, stronger retention. The warehouse is the proving ground. Read the full breakdown 👉 https://illustrated-ai.com/ultras-warehouse-robots-move-from-hype-to-real-orders/

09/10/2026

Quantum computing just got a serious capital vote of confidence. Oratomics jumped from a $1.5B to $5.4B valuation in roughly three months — not because of current profits, but because investors see a rare inflection point. The real prize? Fault tolerance. Quantum machines fail because qubits are fragile. A fault-tolerant system corrects its own errors, shifting quantum from lab curiosity to real-world utility. Oratomics is targeting 10,000–20,000 atomic qubits using neutral-atom architecture — a flexible, scalable approach that could unlock breakthroughs in drug discovery, materials science, and beyond. Big valuations are signals, not verdicts. The money has arrived. Now the machine must. 🔗 https://illustrated-ai.com/oratomics-5-4b-quantum-leap-in-private-markets/

08/10/2026

AI infrastructure demand at Lambda just went from $15B to $50B in months — not gradual growth, but a market kicking down the door. Companies now treat advanced AI as strategic infrastructure, not a research experiment. But scaling isn't weightless: more demand means more machines, power, cooling, and capital. Whoever controls that physical foundation becomes critical to the entire ecosystem. There's a catch though — much of Lambda's backlog appears tied to a single customer, adding concentration risk that sophisticated investors are watching closely. Meanwhile, Lambda's pre-IPO financing strategy links financial engineering directly to GPU deployment — expensive, capital-hungry, but creating real barriers to entry. Big demand gets attention. Real delivery earns trust. 👉 https://illustrated-ai.com/lambdas-ai-cloud-backlog-surge-and-pre-ipo-funding-push-2/

Adresse

Zürich
8001

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Telefon

+41764170605

Website

https://smartprofitfinder.com/

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn Smartprofit Finder etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.